Low sustained virologic response (SVR) rates in genotype (GT) 2 and 3 patients with quantifiable hepatitis C virus (HCV) at weekly 4 or treatment with Sofosbuvir (SOF) containing regimens

Document Type

Other

Publication Date

12-2016

Share

COinS